Candice Delcourt's Publications
About Candice Delcourt's Publications
Senior Research Fellow- Program Head, Neurology
-
Abstract TP371: Adopting a Patient-centered Approach in Acute Stroke Trials With Utility-weighted Modified Rankin Scale Scores
Stroke Date published: -
Abstract WP107: Early Recurrence of Ischemic Stroke in Alteplase-treated Patients: The ENCHANTED Study
Stroke Date published: -
Thrombolysis outcomes in acute ischemic stroke by FLAIR hyper intense arteries
Date published: -
Early Recurrence of Ischemic Stroke in Alteplase-treated Patients: The ENCHANTED Study.
Date published: -
Comparison of the Simplified Modified Rankin Scale Questionnaire With Conventional Neurological Scales in the Dose Arm of the Enchanted Study.
Date published: -
Comparative Effects of Low-dose versus Standard- dose Alteplase in Thrombolysed Ischemic Patients with Low Platelet Count: The ENCHANTED Trial
Date published: -
Baseline brain imaging signs and outcomes in the ENCHANTED trial
Date published: -
Gender representation at the Stroke Society of Australasia conference
Date published: -
Stroke Risk Factors and Outcomes in Indigenous Verse Non-Indigenous Australians
Heart, Lung and Circulation Date published: -
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
The Lancet Neurology Date published: -
NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke
Neurology Date published: -
Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis
BMJ Open Date published: -
Predictors of severity of hypertensive response in acute intracerebral haemorrhage
Date published: -
Comparison between right and left acute ischaemic stroke patients treated with intravenous alteplase in the ENCHANTED trial
Date published: -
To treat acute ischemic stroke with standard-dose or low-dose alteplase? An individualized decision making tool
Date published: -
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine Date published: